This article is more than 5 years old. Information may no longer be current.

DePuy Synthes launches cellular allograft for spinal fusion surgery

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

DePuy Synthes, in collaboration with LifeNet Health, has launched ViviGen Formable cellular bone matrix, a second-generation cellular allograft to assist with bone formation during spinal fusion surgery.

According to a company press release, the ViviGen Formable creates a putty-like consistency and its fibers interconnect to achieve formable handling for open void cases, such as posterolateral fusion. This handling reportedly allows surgeons to mold the allograft, helping the ViviGen Formable to conform to the surgical site.

DePuy Synthes has an exclusive agreement to market and promote ViviGen and ViviGen Formable.

Reference:

www.depuysynthes.com